Viemed Healthcare, Inc. (VMD)
Nasdaq · Services-Misc Health & Allied Services, Nec · Services · CIK 1729149 · fiscal year ends in Dec
Closing price $9.68 on 30 Oct 2026; 52-week range $6.26 to $12.33.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $301.6M
- Revenue growth
- 25.2%
- Net income, last twelve months
- $14.5M
- Earnings per share
- $0.36
- Gross margin
- 57.5%
- Operating margin
- 7.5%
- Net margin
- 4.8%
- Free cash flow
- $29.2M
- Return on equity
- 10.1%
- Market value
- $368.7M
- Price to earnings
- 26.9x
- Cash
- $10.7M
- Debt
- $7.1M
- Debt to equity
- 0.05
- Shares outstanding
- 38.1M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $270.3M | $22.9M | $14.9M | $0.37 | $11.9M | 10-K filed 4 Mar 2026 |
| FY2024 | 31 Dec 2024 | $224.3M | $17.9M | $11.3M | $0.28 | $1.3M | 10-K filed 10 Mar 2025 |
| FY2023 | 31 Dec 2023 | $183.0M | $14.3M | $10.2M | $0.25 | $19.1M | 10-K filed 6 Mar 2024 |
| FY2022 | 31 Dec 2022 | $138.8M | $8.3M | $6.2M | $0.16 | $4.8M | 10-K filed 2 Mar 2023 |
| FY2021 | 31 Dec 2021 | $117.1M | $11.6M | $9.1M | $0.22 | $2.8M | 10-K filed 7 Mar 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $78.1M | $2.8M | $0.07 |
| Q1 FY2026 | 31 Mar 2026 | $75.4M | $2.6M | $0.06 |
| Q4 FY2025 | 31 Dec 2025 | $76.2M | $5.6M | $0.14 |
| Q3 FY2025 | 30 Sep 2025 | $71.9M | $3.5M | $0.09 |
| Q2 FY2025 | 30 Jun 2025 | $63.1M | $3.2M | $0.08 |
| Q1 FY2025 | 31 Mar 2025 | $59.1M | $2.6M | $0.06 |
| Q4 FY2024 | 31 Dec 2024 | $60.7M | $4.3M | $0.10 |
| Q3 FY2024 | 30 Sep 2024 | $58.0M | $3.9M | $0.10 |
Company events
The newest 8-K filings of 91 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 20 Aug 2026 | 8-K | Investor update | 7.01, 9.01 |
| 3 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 4 Jun 2026 | 8-K | Leadership change, Shareholder vote | 5.02, 5.07, 9.01 |
| 2 Jun 2026 | 8-K | Investor update | 7.01, 9.01 |
| 5 May 2026 | 8-K | Results | 2.02, 9.01 |
| 16 Mar 2026 | 8-K | Investor update | 7.01, 9.01 |
| 4 Mar 2026 | 8-K | Results, Investor update, Other events | 2.02, 7.01, 8.01, 9.01 |
| 7 Nov 2025 | 8-K | Material agreement, Investor update | 1.01, 7.01 |
| 5 Nov 2025 | 8-K | Results | 2.02, 9.01 |
| 23 Sep 2025 | 8-K | Investor update, Other events | 7.01, 8.01, 9.01 |
| 6 Aug 2025 | 8-K | Results | 2.02, 9.01 |
| 2 Jul 2025 | 8-K | Investor update | 7.01, 9.01 |
Every filing
The newest filings with the SEC of 164 held.
| Filed | Form | Period |
|---|---|---|
| 20 Aug 2026 | 8-K | 20 Aug 2026 |
| 5 Aug 2026 | S-8 | – |
| 3 Aug 2026 | 10-Q | 30 Jun 2026 |
| 3 Aug 2026 | 8-K | 3 Aug 2026 |
| 4 Jun 2026 | 8-K | 4 Jun 2026 |
| 2 Jun 2026 | 8-K | 2 Jun 2026 |
| 5 May 2026 | 10-Q | 31 Mar 2026 |
| 5 May 2026 | 8-K | 5 May 2026 |
| 22 Apr 2026 | DEF 14A | 22 Apr 2026 |
| 22 Apr 2026 | DEFA14A | – |
| 22 Apr 2026 | ARS | 31 Dec 2025 |
| 16 Mar 2026 | 8-K | 16 Mar 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 25 Jun 2026 | Frazier William, Chief Medical Officer | Sale outside a trading plan | 10,000 | $11.72 | $117.2K | 73,214 | 26 Jun 2026 |
| 24 Jun 2026 | Smokoff Timothy, Director | Sale outside a trading plan | 1,636 | $11.48 | $18.8K | 93,882 | 26 Jun 2026 |
| 24 Jun 2026 | Smokoff Timothy, Director | Sale outside a trading plan | 3,364 | $11.50 | $38.7K | 90,518 | 26 Jun 2026 |
| 24 Jun 2026 | Smokoff Timothy, Director | Sale outside a trading plan | 5,000 | $11.56 | $57.8K | 85,518 | 26 Jun 2026 |
| 24 Jun 2026 | Smokoff Timothy, Director | Sale outside a trading plan | 5,000 | $11.53 | $57.6K | 80,518 | 26 Jun 2026 |
| 24 Jun 2026 | Smokoff Timothy, Director | Sale outside a trading plan | 5,000 | $11.41 | $57.0K | 75,518 | 26 Jun 2026 |
| 20 Mar 2026 | Moore Michael, President | Sale outside a trading plan | 65,000 | $8.77 | $570.0K | 1,585,812 | 20 Mar 2026 |
| 19 Mar 2026 | Moore Michael, President | Sale outside a trading plan | 40,232 | $9.21 | $370.5K | 1,650,812 | 20 Mar 2026 |
| 18 Mar 2026 | Moore Michael, President | Sale outside a trading plan | 31,570 | $9.42 | $297.4K | 1,691,044 | 20 Mar 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 20 Mar 2026 | MOORE FASTER LLC, Officer | 65,000 | $570.1K | 20 Mar 2026 |
| 19 Mar 2026 | MOORE FASTER LLC, Officer | 40,232 | $370.4K | 19 Mar 2026 |
| 18 Mar 2026 | MOORE FASTER LLC, Officer | 31,570 | $297.3K | 18 Mar 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 24 Sep 2026 | Michael Moore | 13D amended | 5.9% | 2.3M |
| 24 Jul 2026 | Forager Capital Management, LLC | 13G amended | 4.9% | 1.9M |
| 7 Nov 2025 | Forager Capital Management, LLC | 13G amended | 7.2% | 2.7M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 1.5M | -2.16% | 6.4 |
| 30 Sep 2026 | 1.6M | +18.53% | 5.67 |
| 15 Sep 2026 | 1.3M | +9.65% | 5.24 |
| 31 Aug 2026 | 1.2M | +53.38% | 2.81 |
| 14 Aug 2026 | 787.1K | +17.18% | 1.34 |
| 31 Jul 2026 | 671.7K | -10.08% | 2.49 |
| 15 Jul 2026 | 747.1K | +43.92% | 2.38 |
| 30 Jun 2026 | 519.1K | +11.74% | 1.18 |
Funds that hold it
From each fund's latest Form 13F.
177 funds held it at 30 Jun 2026: 94 added and 33 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 4,788,307 | $54.6M | +165,745 |
| Forager Capital Management, LLC | 2,141,184 | $24.4M | -684,687 |
| Vanguard Capital Management LLC | 1,321,676 | $15.1M | +18,292 |
| Nantahala Capital Management, LLC | 1,264,890 | $14.4M | – |
| Goldman Sachs Group Inc. | 1,222,534 | $13.9M | -199,100 |
| First Eagle Investment Management, LLC | 1,070,314 | $12.2M | – |
| Ameriprise Financial Inc. | 1,006,195 | $11.5M | +107,876 |
| Geode Capital Management, LLC | 973,744 | $11.1M | +194,222 |
| Raffles Associates LP | 807,382 | $9.2M | +393,691 |
| Arrowstreet Capital, Limited Partnership | 786,269 | $9.0M | +75,083 |
Peers
Companies in the same industry.
- Davita Inc. (DVA): revenue $14.2B, market value $11.9B
- Sotera Health Co. (SHC): revenue $1.2B, market value $5.2B
- Progyny, Inc. (PGNY): revenue $1.3B, market value $2.3B
- agilon health, Inc. (AGL): revenue $5.9B, market value $1.4B
- Park Dental Partners, Inc. (PARK): revenue –, market value $99.4M